Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1993;88:1021-1029

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wever, E. F.
Right arrow Articles by Robles de Medina, E. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wever, E. F.
Right arrow Articles by Robles de Medina, E. O.

Circulation, Vol 88, 1021-1029, Copyright © 1993 by American Heart Association


ARTICLES

Unfavorable outcome in patients with primary electrical disease who survived an episode of ventricular fibrillation

EF Wever, RN Hauer, A Oomen, RH Peters, PF Bakker and EO Robles de Medina
Department of Cardiology, University Hospital Utrecht, The Netherlands.

BACKGROUND. Prognosis in patients with ventricular tachyarrhythmia without structural heart disease (primary electrical disease) has been described as excellent. However, prognosis may be less favourable in the subgroup surviving an episode of ventricular fibrillation. METHODS AND RESULTS. We prospectively followed 19 consecutive patients (age, 13 to 66 years; mean age, 33 years) who had survived an episode of documented ventricular fibrillation. Structural heart disease, preexcitation, and long QT syndromes were excluded by thorough cardiologic evaluation. All patients underwent 24-hour Holter monitoring, exercise testing, and programmed electrical stimulation according to a standardized protocol. Holter monitoring revealed episodes of ventricular tachyarrhythmia in 5 patients. Exercise testing reproducibly provoked ventricular tachycardia in 2 patients. Baseline programmed electrical stimulation yielded inducibility of rapid ventricular tachyarrhythmia in 10 patients (53%) and noninducibility in 9 (47%). Nine patients were discharged on antiarrhythmic drug therapy. A defibrillator was implanted in 10 patients. During 43-month follow-up (range, 5 to 85 months; median, 41 months), major arrhythmic events recurred in 7 patients (37%). Four of these patients had noninducibility at baseline programmed electrical stimulation. Two patients on antiarrhythmic drugs had recurrent cardiac arrest: one died suddenly and the other was successfully resuscitated from ventricular fibrillation and subsequently underwent defibrillator implantation. In the other 5 patients, termination of (pre)syncopal episodes was associated with defibrillator shocks. Termination of ventricular fibrillation was documented by Holter recording in one of these patients. Specific markers predictive of a recurrent event could not be identified, although 6 of 7 patients with recurrent events had experienced at least one episode of cardiac arrest or (pre)syncope before the index episode. CONCLUSIONS. Patients with primary electrical disease presenting with ventricular fibrillation are at high risk of recurrence of major arrhythmic events during long-term follow-up. Noninducibility at baseline study does not predict an uneventful course. Also, early defibrillator implantation should be considered in these patients.


This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
N. Cui, L. Li, X. Wang, Y. Shi, W. Shi, and C. Jiang
Elimination of allosteric modulation of myocardial KATP channels by ATP and protons in two Kir6.2 polymorphisms found in sudden cardiac death
Physiol Genomics, March 13, 2006; 25(1): 105 - 115.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. de Torbal, E. Boersma, J. A. Kors, G. van Herpen, J. W. Deckers, D. A.M. van der Kuip, B. H. Stricker, A. Hofman, and J. C.M. Witteman
Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study
Eur. Heart J., March 2, 2006; 27(6): 729 - 736.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. F. D. Wever and E. O. Robles de Medina
Sudden death in patients without structural heart disease
J. Am. Coll. Cardiol., April 7, 2004; 43(7): 1137 - 1144.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R.N.W. Hauer, E. Aliot, M. Block, A. Capucci, B. Luderitz, M. Santini, and P.E. Vardas
Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology
Eur. Heart J., July 1, 2001; 22(13): 1074 - 1081.
[PDF]


Home page
Cardiovasc ResHome page
G. Gronefeld and S. H Hohnloser
What do implantable cardioverter/defibrillators teach us about the mechanisms of sudden cardiac death?
Cardiovasc Res, May 1, 2001; 50(2): 232 - 241.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C.A Remme, E.F.D Wever, A.A.M Wilde, R Derksen, and R.N.W Hauer
Diagnosis and long-term follow-up of the Brugada syndrome in patients with idiopathic ventricular fibrillation
Eur. Heart J., March 1, 2001; 22(5): 400 - 409.
[Abstract] [PDF]


Home page
EuropaceHome page
N. Samniah, D. Iskos, S. Sakaguchi, K. G. Lurie, and D. G. Benditt
Syncope in pharmacologically unmasked Brugada syndrome: indication for an implantable defibrillator or an unresolved dilemma?
Europace, January 1, 2001; 3(2): 159 - 163.
[Abstract] [PDF]


Home page
EuropaceHome page
R. N. W. Hauer, E. Aliot, M. Block, A. Capucci, B. Luderitz, M. Santini, and P. E. Vardas
Indications for implantable cardioverter defibrillator (ICD) therapy: Study Group on Guidelines on ICD of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology
Europace, January 1, 2001; 3(3): 169 - 176.
[PDF]


Home page
J Am Coll CardiolHome page
M. Kakishita, T. Kurita, K. Matsuo, A. Taguchi, K. Suyama, W. Shimizu, N. Aihara, S. Kamakura, F. Yamamoto, J. Kobayashi, et al.
Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy
J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1646 - 1653.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S Viskin, R Fish, M Eldar, D Zeltser, M D Lesh, A Glick, and B Belhassen
Prevalence of the Brugada sign in idiopathic ventricular fibrillation and healthy controls
Heart, July 1, 2000; 84(1): 31 - 36.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Brugada, J. Brugada, C. Antzelevitch, G. E. Kirsch, D. Potenza, J. A. Towbin, and P. Brugada
Sodium Channel Blockers Identify Risk for Sudden Death in Patients With ST-Segment Elevation and Right Bundle Branch Block but Structurally Normal Hearts
Circulation, February 8, 2000; 101(5): 510 - 515.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
O. Berenfeld and J. Jalife
Purkinje-Muscle Reentry as a Mechanism of Polymorphic Ventricular Arrhythmias in a 3-Dimensional Model of the Ventricles
Circ. Res., June 1, 1998; 82(10): 1063 - 1077.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Brugada, R. Brugada, and P. Brugada
Right Bundle-Branch Block and ST-Segment Elevation in Leads V1 Through V3 : A Marker for Sudden Death in Patients Without Demonstrable Structural Heart Disease
Circulation, February 10, 1998; 97(5): 457 - 460.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Survivors of Out-of-Hospital Cardiac Arrest With Apparently Normal Heart: Need for Definition and Standardized Clinical Evaluation
Circulation, January 7, 1997; 95(1): 265 - 272.
[Abstract] [Full Text]


Home page
CirculationHome page
E. F.D. Wever, R. N.W. Hauer, G. Schrijvers, F. J.L. van Capelle, J. G.P. Tijssen, H. J.G.M. Crijns, A. Algra, H. Ramanna, P. F.A. Bakker, and E. O. Robles de Medina
Cost-effectiveness of Implantable Defibrillator as First-Choice Therapy Versus Electrophysiologically Guided, Tiered Strategy in Postinfarct Sudden Death Survivors : A Randomized Study
Circulation, February 1, 1996; 93(3): 489 - 496.
[Abstract] [Full Text]


Home page
CirculationHome page
R.C. Saumarez, S. Heald, J. Gill, A.K.B. Slade, M. de Belder, F. Walczak, E. Rowland, D.E. Ward, and A.J. Camm
Primary Ventricular Fibrillation Is Associated With Increased Paced Right Ventricular Electrogram Fractionation
Circulation, November 1, 1995; 92(9): 2565 - 2571.
[Abstract] [Full Text]